DEA Reschedules All Hydrocodone-Containing Products
Effective October 6, 2014, all hydrocodone-containing products will be classified Schedule II controlled substances. To read DEA's Final Rule, click the following link: http://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0822.htm.
Third-party Reviews of Prescriber or Pharmacy EPCS Applications
DEA has approved additional certifying organizations' processes to certify systems for electronic prescribing of controlled substances. See http://www.deadiversion.usdoj.gov/ for more information.